HOME >> BIOLOGY >> NEWS
Imaging technique may help in confirming, monitoring treatment of malignant brain tumors

In what is believed to be a first-of-its-kind study, Johns Hopkins researchers have used magnetic resonance imaging (MRI) to measure sodium concentrations in the cells of malignant brain tumors. Because growth of such cancers are linked to elevated sodium levels, an easy way to measure them could improve diagnosis and treatment monitoring. The study is published in the May 1 edition of Radiology.

"Determining precise sodium concentrations has been a problem, but MRI can do it at the same time it identifies possible malignant lesions," says Ronald Ouwerkerk, Ph.D., instructor of radiology at the Johns Hopkins Department of Radiology, MRI Research Division. Using proton MRI after injecting contrast agents to enhance areas containing many small blood vessels, the researchers found 50 percent more sodium in lesions that turned out to be malignant tumors than in normal brain tissue.

"Using MRI noninvasively in a single examination to get information about tumor metabolism and physiology improves identification of tumor malignancy and is a big step forward," says Ouwerkerk.

In the Hopkins study, 20 patients with brain malignancies confirmed by biopsy and nine subjects with no brain tumors underwent sodium MRI. Sodium concentrations were determined in malignant tumors, gray brain matter, white brain matter, cerebrospinal fluid and vitreou s humor (fluid within the eye). The image intensities in the sodium images were compared with the signals from a sample with known sodium content. The special scan method the researchers use for three-dimensional sodium MRI makes it possible to directly calculate sodium concentrations.

The researchers found sodium concentrations in cancer cells were elevated by an average of 50 percent compared to the other noncancerous tissues or those tissues in subjects with no tumors.

Elevated sodium, as an indicator of cancer, may be due to several factors. Among them are angiogenesis, development o
'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
1-May-2003


Page: 1 2

Related biology news :

1. Imaging the healing heart
2. Imaging study shows brain maturing
3. Imaging the brain solving problems through insight
4. Imaging technique reveals new structure in retinal cells
5. Imaging technique discovered at Stanford monitors cancer cell proliferation
6. Imaging study provides new information on how the brain processes sounds of different tones
7. Imaging apparatus characterizes drops in dirty laboratory environments
8. New Imaging Technique Pinpoints Dead Heart Muscle
9. Imaging Studies Illuminate Brains Response To Cocaine
10. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
11. New technique helps scientists reveal interactions between genes and drugs

Post Your Comments:
(Date:4/17/2014)... engineer has developed a patented technique that improves ... The same technique could help police during drug ... Kay L. Theede chair in engineering and department ... research team have created a template-based system that ... The distance detection method called stand-off bomb ...
(Date:4/17/2014)... is available in German . ... the protection money demanded of him, he can expect his ... however, as fear of the consequences is enough to make ... parasitic birds, which lay their eggs in other birds, nests. ... brood parasites take their revenge by destroying the entire nest. ...
(Date:4/17/2014)... many serious conditions such as heart disease, epilepsy and ... therapies. Unfortunately, there is still much scientists do not ... and unexpected insight into the structure of sodium channels ... - which are responsible for ,fine-tuning, the activity of ... recent edition of the Journal of Biological Chemistry ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Structure of sodium channels different than previously believed 2
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
(Date:1/14/2014)... Boston, MA (PRWEB) January 14, 2014 iLab ... Michelle Detwiler as the new Director of Product Strategy. In ... as well as iLab sub-teams to guide in the development ... that iLab provides the maximum possible benefit to the scientific ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... 2014   Kinaxis ®, provider of RapidResponse ®, a ... operations planning ( S&OP ) service, is proud to be ... will be held at the Hilton San Diego Bayfront, January ... Elisabeth Kaszas , Director of Supply Chain at Amgen, ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: